- Monthly visits
- 9.9K
- Up7.2%MoMOct 2026
- Public revenue
- Undisclosed
- No public revenue evidence yet
- Entry price
- Unknown
- No monthly subscription pricing
- Creators
- Unlinked
- No verified creators
- Launched
- 3y ago
- 2023-10-30 · Est.
Traffic
Marketing moves
Launches, search & content, referrals, promotionsNew product launchLaunch
Oct 30, 2023 · 3y agoWebsite
Traffic sources
Oct 2026
Traffic breakdown
Channels
- Direct28%
- Organic Search25%
- Display Ads24%
- Referrals10%
- Other13%
Countries
- Russia92%
- Belarus8%
Search
Domain authority —Domain registered 2023-10-30
| Keyword | Monthly volume |
|---|---|
| нимесулид для чего | 1,310 |
| нимесулид от чего | 810 |
| циннаризин от чего | 490 |
| анаприлин инструкция | 240 |
| татхимпрепараты | 140 |
Traffic data: Vaneform
Pricing
Pricing page not identified yet, or no public pricing listed.
Pages & changes
Tracked since 2026-11-04
Key pages
Weekly snapshotstatpharm.ru/ Snapshot 2026-11-05
Changes
No pricing, plan, or positioning changes detected since tracking started.
Design
First-screen visual analysis & :root CSS
Enterprise Clean (Dark canvas, airy density) featuring centered headline + cta layout and photography / live video visuals.
First-screen preview · click to zoom
First-screen pitch & conversion flow
“АО «ТАТХИМФАРМПРЕПАРАТЫ»”
Centered Headline + CTA hero structure paired with book demo / contact sales CTA and no explicit trust bar.
Conversion path: Centered Headline + CTA + Photography / Live Video → Book Demo / Contact Sales
- Category Positioning Anchor
Palette · click to copy
5-D design score7.1 / 10
- Typography
- 7.0
- Color & Contrast
- 7.0
- Layout & Spacing
- 8.0
- Craft & Polish
- 7.0
- Distinctiveness
- 6.0
Structure
- Fonts
- Arial
- Hero layout
- Centered Headline + CTA
- Primary visual
- Photography / Live Video
- Conversion CTA
- Book Demo / Contact Sales
- Social proof
- No Explicit Trust Bar
- Navigation
- Full-Width Top Bar
- Theme & density
- Dark · Airy
- Corners & depth
- Sharp · Hairline borders
Preview full AI design brief (includes :root CSS variables & layout rules)Style tokens only; never copy brand names, logos, copy, or images
# Design Brief: Enterprise Clean
Trustworthy blue-anchored palette, structured grids, and prominent customer logo walls.
## Design Tokens
```css
:root {
--background: #062d3d;
--surface: #ffffff;
--foreground: #ffffff;
--muted-foreground: #d5d8db;
--accent: #b51f35;
--radius: 0px;
--font-heading: "Arial", ui-sans-serif, system-ui, sans-serif;
--font-body: "Arial", ui-sans-serif, system-ui, sans-serif;
}
```
Color area ratio: Background #062D3D (~68%) · Surface #FFFFFF (~8%) · Text #FFFFFF (~15%) · Muted Text #D5D8DB (~7%) · Accent #B51F35 (~2%). Background and surface dominate the canvas; reserve the accent color for primary buttons and active states.
## Layout & Conversion Structure
- Hero layout: Centered Headline + CTA
- Navigation: Full-Width Top Bar
- Theme & density: Dark · Airy
- Border radius & elevation: Sharp; no drop shadows—separate layers with hairline borders and whitespace
- Primary visual medium: Photography / Live Video
- Conversion CTA: Book Demo / Contact Sales
- Headline hook: Category Positioning Anchor
- Spatial layout notes: Centered Headline + CTA hero structure paired with book demo / contact sales CTA and no explicit trust bar.
- Visual summary: Enterprise Clean (Dark canvas, airy density) featuring centered headline + cta layout and photography / live video visuals.
## Avoid
- Experimental navigation patterns
- Low-legibility decorative fonts
- Visual novelty that obscures the value proposition
Implement the UI following the design tokens and layout specifications above: use only these color variables, and reserve the accent color strictly for primary actions and active states. Adopt only this visual style—never copy any reference product’s brand name, logo, copy, or imagery.
Questions & evidence
- How much website traffic does Tatpharm get?
- Vaneform estimates 9.9K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
- What is Tatpharm and what platforms does it support?
- Tatpharm is catalogued under Life Sciences & Biotech: ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ. Supported platforms: Web.
Related products in this category
Industry Software / Life Sciences & Biotech
These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.
| Product | Entry price | Visits | Revenue |
|---|---|---|---|
| Fierce BiotechMatureFierce Biotech News & Reports | — | 879.4K | Undisclosed |
| 田辺ファーマ株式会社Develops innovative medicines for people facing illness. | — | 393.4K | Undisclosed |
| Certified-PepThe Most Trusted Name in Research Peptides | — | 323.2K | Undisclosed |
| EvidentWe are guided by the scientific spirit. Evident creates advanced life science and industrial microscopy solutions that help make the world… | — | 305.9K | Undisclosed |
| AlphaFold ServerAlphaFold Server – powered by AlphaFold 3 – provides accurate structure predictions for how proteins interact with other molecules, like DNA | — | 299.4K | Undisclosed |
| RxTra ClinicalYour Clinical Trials Concierge. | — | 296.9K | Undisclosed |